MRNA vs POST · rev $1.94B vs P/E 15, rev $8.16B
Moderna Inc (MRNA) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
MRNA currently screens at market cap $24.52B. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the MRNA and POST stock pages for the full models.
Not investment advice.